In Vitro Activity of the New Ketolide Telithromycin Compared with Those of Macrolides against Streptococcus pyogenes : Influences of Resistance Mechanisms and Methodological Factors
- 1 November 2000
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (11) , 2999-3002
- https://doi.org/10.1128/aac.44.11.2999-3002.2000
Abstract
One hundred and seven clinical isolates of Streptococcus pyogenes , 80 susceptible to macrolides and 27 resistant to erythromycin A (MIC >0.5 μg/ml), were examined. The erythromycin A-lincomycin double-disk test assigned 7 resistant strains to the M-phenotype, 8 to the inducible macrolide, lincosamide, and streptogramin B resistance (iMLS B ) phenotype, and 12 to the constitutive MLS B resistance (cMLS B ) phenotype. MICs of erythromycin A, clarithromycin, azithromycin, roxithromycin, and clindamycin were determined by a broth microdilution method. MICs of telithromycin were determined by three different methods (broth microdilution, agar dilution, and E-test methods) in an ambient air atmosphere and in a 5 to 6% CO 2 atmosphere. Erythromycin A resistance genes were investigated by PCR in the 27 erythromycin A-resistant isolates. MICs of erythromycin A and clindamycin showed six groups of resistant strains, groups A to F. iMLS B strains (A, B, and D groups) are characterized by two distinct patterns of resistance correlated with genotypic results. A- and B-group strains were moderately resistant to 14- and 15-membered ring macrolides and highly susceptible to telithromycin. All A- and B-group isolates harbored erm TR gene, D-group strains, highly resistant to macrolides and intermediately resistant to telithromycin (MICs, 1 to 16 μg/ml), were all characterized by having the ermB gene. All M-phenotype isolates (C group), resistant to 14- and 15-membered ring macrolides and susceptible to clindamycin and telithromycin, harbored the mefA gene. All cMLS B strains (E and F groups) with high level of resistance to macrolides, lincosamide, and telithromycin had the ermB gene. The effect of 5 to 6% CO 2 was remarkable on resistant strains, by increasing MICs of telithromycin from 1 to 6 twofold dilutions against D-E- and F-group isolates.Keywords
This publication has 18 references indexed in Scilit:
- Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in ItalyJournal of Antimicrobial Chemotherapy, 1999
- Phenotypes and Genotypes of Erythromycin-Resistant Streptococcus pyogenes Strains in Italy and Heterogeneity of Inducibly Resistant StrainsAntimicrobial Agents and Chemotherapy, 1999
- Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycinJournal of Antimicrobial Chemotherapy, 1999
- Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.1999
- Molecular cloning and functional analysis of a novel macrolide‐resistance determinant, mefA, from Streptococcus pyogenesMolecular Microbiology, 1996
- Erythromycin resistance by ribosome modificationAntimicrobial Agents and Chemotherapy, 1995
- Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in FinlandJournal of Antimicrobial Chemotherapy, 1993
- Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modificationAntimicrobial Agents and Chemotherapy, 1991
- Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: The resistance phenotype, its biological diversity, and structural elements that regulate expression - A reviewJournal of Antimicrobial Chemotherapy, 1985
- Inducible and Constitutive Resistance to Macrolide Antibiotics and Lincomycin in Clinically Isolated Strains of Streptococcus pyogenesAntimicrobial Agents and Chemotherapy, 1973